BMC Endocrine Disorders (Dec 2002)

Treatment of hyperfunctioning thyroid nodules by percutaneous ethanol injection

  • Sarai Maryam,
  • Amini Mohammad-Reza,
  • Shirzad Mahmood,
  • Firooznia Kazem,
  • Abbasvandi Fereshteh,
  • Bastanhagh Mohammad-Hassan,
  • Ghanaati Hossein,
  • Pajouhi Mohammad,
  • Larijani Bagher,
  • Abbasvandi Nasreen,
  • Baradar-Jalili Reza

DOI
https://doi.org/10.1186/1472-6823-2-3
Journal volume & issue
Vol. 2, no. 1
p. 3

Abstract

Read online

Abstract Background Autonomous thyroid nodules can be treated by a variety of methods. We assessed the efficacy of percutaneous ethanol injection in treating autonomous thyroid nodules. Methods 35 patients diagnosed by technetium-99 scanning with hyperfunctioning nodules and suppressed sensitive TSH (sTSH) were given sterile ethanol injections under ultrasound guidance. 29 patients had clinical and biochemical hyperthyroidism. The other 6 had sub-clinical hyperthyroidism with suppressed sTSH levels (3, T4 and sTSH levels had returned to normal, or else injections could no longer be performed because significant side effects. Patients were followed up at 3, 6 and, in 15 patients, 24 months after the last injection. Results Average pre-treatment nodule volume [18.2 ± 12.7 ml] decreased to 5.7 ± 4.6 ml at 6 months follow-up [P 4 and sTSH did not change significantly between 6 months and 2 years [P > 0.05]. Ethanol injections were well tolerated by the patients, with only 2 cases of transient dysphonia. Conclusion Our findings indicate that ethanol injection is an alternative to surgery or radioactive iodine in the treatment of autonomous thyroid nodules.

Keywords